Your browser doesn't support javascript.
loading
Racial differences in hypogonadal improvement and prostate-specific antigen levels in hypogonadal men treated with testosterone replacement therapy.
Coward, Robert M; Simhan, Jay; Carson, Culley C.
Afiliación
  • Coward RM; Division of Urologic Surgery, The University of North Carolina, Chapel Hill, North Carolina 27599-7235, USA. rcoward@unch.unc.edu
Int Braz J Urol ; 36(6): 700-7; discussion 707-9, 2010.
Article en En | MEDLINE | ID: mdl-21176276
PURPOSE: To observe hypogonadal men undergoing testosterone replacement therapy (TRT) and assess racial differences in hypogonadal improvement and prostate-specific antigen (PSA) levels. MATERIALS AND METHODS: In a retrospective analysis, 75 hypogonadal men were followed for an average 34 months after initiating TRT. Total testosterone and PSA levels were assessed every 6 months, and patients diagnosed with prostatitis or prostate cancer during treatment were excluded. RESULTS: For 16 African American men, the average age at diagnosis of hypogonadism was 53.5 years, compared with 57.8 years in 59 Caucasian men (p=NS). Pre- and post-treatment testosterone was 219 ng/dL and 310 ng/dL in African American men, and 247 ng/dL and 497 ng/dL in Caucasian men (p=NS). Symptomatic response was 81% in African American men and 93% in Caucasian men (p=NS). Baseline PSA level was 1.32 ng/mL in African American men and 1.27 ng/mL in Caucasian men, and there was no significant difference in PSA between racial groups at 6-month intervals, although there was a small decreasing trend in the PSA of African Americans compared with Caucasians. CONCLUSIONS: Hypogonadal African American men have a similar normalization of testosterone and symptomatic response as hypogonadal Caucasian men, and PSA levels remain stable over time in both groups. In this hypogonadal cohort, in contrast to studies of eugonadal men, higher PSA levels in African Americans were not observed.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Testosterona / Antígeno Prostático Específico / Terapia de Reemplazo de Hormonas / Hipogonadismo Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Int Braz J Urol Asunto de la revista: UROLOGIA Año: 2010 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Brasil
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Testosterona / Antígeno Prostático Específico / Terapia de Reemplazo de Hormonas / Hipogonadismo Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Int Braz J Urol Asunto de la revista: UROLOGIA Año: 2010 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Brasil